Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.
Kathryn Ruddy, MD
Advertisement
Articles by Kathryn Ruddy, MD
Kathryn Ruddy, MD, associate professor of Oncology, Mayo Clinic, discusses the management of central nervous system (CNS) metastases in HER2-positive breast cancer.
Kathryn Ruddy, MD, discusses how genetic testing could impact treatment of patients with breast cancer.
Advertisement
Latest Updated Articles
Dr. Ruddy on the Management of CNS Metastases in HER2+ Breast CancerNovember 5th 2018
Dr. Ruddy on the Importance of Genetic Testing in Breast CancerOctober 13th 2018
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC
2
FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma
3
Rocbrutinib Displays Durable Activity in Covalent BTK Inhibitor–Pretreated R/R MCL
4
Risvutatug Rezetecan Shows OS Benefit Over Topotecan in Relapsed SCLC
5